Alnylam Pharmaceuticals
ALNY
#728
Rank
S$44.81 B
Marketcap
S$334.95
Share price
-1.08%
Change (1 day)
-41.82%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company